Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Microbiome-based interventions: therapeutic strategies in cancer immunotherapy.
Electronic tools to assist with identification and counseling for overweight patients: a randomized controlled trial.
Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study.
Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat. 2023 Sep; 201(2):257-264.
View in:
PubMed
subject areas
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Female
Genes, BRCA1
Humans
Mutation
Raloxifene Hydrochloride
Risk Factors
Tamoxifen
authors with profiles
Olufunmilayo Olopade